1,683 results on '"Kramer, Christopher M."'
Search Results
52. ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 Appropriate Use Criteria for Multimodality Imaging in the Assessment of Cardiac Structure and Function in Nonvalvular Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and the Society of Thoracic Surgeons
53. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease: A report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons
54. High-risk plaque in the superficial femoral artery of people with peripheral artery disease: Prevalence and associated clinical characteristics
55. Collateral vessel number, plaque burden, and functional decline in peripheral artery disease
56. High‐resolution spiral real‐time cardiac cine imaging with deep learning‐based rapid image reconstruction and quantification
57. Magnetic Resonance Imaging Techniques in Peripheral Arterial Disease
58. Perfusion Imaging for the Heart
59. Toward Replacing Late Gadolinium Enhancement With Artificial Intelligence Virtual Native Enhancement for Gadolinium-Free Cardiovascular Magnetic Resonance Tissue Characterization in Hypertrophic Cardiomyopathy
60. Myocardial Viability Testing to Guide Coronary Revascularization
61. ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2017 Appropriate Use Criteria for Multimodality Imaging in Valvular Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons
62. ACC/AATS/AHA/ASE/EACTS/HVS/SCA/SCAI/SCCT/SCMR/STS 2017 Appropriate Use Criteria for the Treatment of Patients With Severe Aortic Stenosis: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Valve Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons
63. Role of Cardiac Magnetic Resonance in the Diagnosis and Prognosis of Nonischemic Cardiomyopathy
64. The Potential of Clinical Phenotyping of Heart Failure With Imaging Biomarkers for Guiding Therapies: A Focused Update
65. ACR Appropriateness Criteria® Acute Chest Pain—Suspected Pulmonary Embolism
66. ACR Appropriateness Criteria® Dyspnea—Suspected Cardiac Origin
67. Prognostic Value of Myocardial Scarring on CMR in Patients With Cardiac Sarcoidosis
68. Non-invasive assessment of low- and intermediate-risk patients with chest pain
69. Multimodality Imaging for Hypertrophic Cardiomyopathy
70. Standardized image interpretation and post-processing in cardiovascular magnetic resonance - 2020 update: Society for Cardiovascular Magnetic Resonance (SCMR): Board of Trustees Task Force on Standardized Post-Processing
71. Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update
72. High‐resolution spiral real‐time cardiac cine imaging with deep learning‐based rapid image reconstruction and quantification.
73. 44 - Noninvasive Cardiac Imaging
74. Advanced Peripheral Artery Vessel Wall Imaging and Future Directions
75. Magnetic Resonance Measures of Calf Muscle Physiology in PAD
76. Contributors
77. Acute Myocardial Infarction
78. Guidelines for Cardiovascular Magnetic Resonance
79. Abstract 16755: Personalized Virtual Cardiac Resynchronization Therapy Simulation Based on a 12-Lead ECG and CMR Predicts Electrical Activation Changes After Cardiac Resynchronization Therapy
80. Abstract 16702: Myocardial Deformation Analysis in Hypertrophic Cardiomyopathy With Sarcomere Mutations: Insights From 2,221 Patients Within the NHLBI-HCM Registry
81. Multimodality Imaging in Hypertrophic Cardiomyopathy for Risk Stratification
82. Progressive Cardiac Metabolic Defects Accompany Diastolic and Severe Systolic Dysfunction in Spontaneously Hypertensive Rat Hearts
83. Alirocumab and plaque volume, calf muscle blood flow, and walking performance in peripheral artery disease: A randomized clinical trial
84. Role of Perfusion at Rest in the Diagnosis of Myocardial Infarction Using Vasodilator Stress Cardiovascular Magnetic Resonance
85. Evidence Base for Quality Control Activities in Cardiovascular Imaging
86. Cardiovascular magnetic resonance detects the progression of impaired myocardial perfusion reserve and increased left-ventricular mass in mice fed a high-fat diet
87. Robust free-breathing SASHA T1 mapping with high-contrast image registration
88. Effectiveness of integrating delayed computed tomography angiography imaging for left atrial appendage thrombus exclusion into the care of patients undergoing ablation of atrial fibrillation
89. Comparison of an initial risk-based testing strategy vs usual testing in stable symptomatic patients with suspected coronary artery disease: the PRECISE randomized ttrial
90. Deferred testing in stable outpatients with suspected coronary artery disease: a prespecified secondary analysis of the PRECISE randomized clinical trial
91. Extracellular volume by cardiac magnetic resonance is associated with biomarkers of inflammation in hypertensive heart disease
92. Fourteen-Year Follow-Up Cardiac Magnetic Resonance Imaging of a Large Septal Cardiac Fibroma
93. Extracellular volume by cardiac magnetic resonance is associated with biomarkers of inflammation in hypertensive heart disease
94. Contemporary Issues in Quantitative Myocardial Perfusion CMR Imaging
95. Recent Advances in Imaging of Hypertensive Heart Disease
96. Great Debate: Computed tomography coronary angiography should be the initial diagnostic test in suspected angina
97. SYMPTOMATIC NON-SUSTAINED VT: CARDIAC MAGNETIC RESONANCE IMAGING CHANGES MANAGEMENT IN THE NICK OF TIME
98. AFICAMTEN IN PATIENTS WITH SYMPTOMATIC NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY (REDWOOD-HCM COHORT 4)
99. UNRAVELING A RIGHT ATRIAL MASS
100. EARLY REFERRAL TO A HYPERTROPHIC CARDIOMYOPATHY CENTER OF EXCELLENCE MAY IMPROVE DIAGNOSTIC ACCURACY AND ENHANCE HEALTHCARE DELIVERY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.